Nexo Therapeutics
Jenifer Winters, Ph.D is a highly experienced and accomplished professional in the field of biochemistry and computational chemistry. With a strong background in research and teaching, Jenifer has worked at various prestigious institutions such as nexo therapeutics, C4 Therapeutics, Inc., and Vertex Pharmaceuticals. Jenifer's expertise lies in structural biology, biophysics, and crystallography, with a focus on drug discovery and protein engineering. Having completed a Doctor of Philosophy in Chemistry and Chemical Biology, Jenifer is dedicated to advancing scientific knowledge and mentoring the next generation of scientists.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.